
Although several macroeconomic headwinds marred the overall economy, the pharmaceutical companies fared comparatively well due to the inelastic demand for its products.
Given this backdrop, let us delve deeper into some pharmaceutical stocks, Novo Nordisk A/S (NVO), Bristol-Myers Squibb Company (BMY), and Takeda Pharmaceutical Company Limited (TAK) now.